Company / Current Liabilities
Zimmer Biomet Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$2.6B
FY2025
5-year range
$2.4B / $3.5B
FY2021-FY2025
Trend
+5.4%
vs FY2024
Sector context
#28 of 160
Health Care
What the data says
Zimmer Biomet's current liabilities of $2.6B is higher than 83% of companies in the Health Care sector (FY2025). Current Liabilities has fluctuated over the past 10 years, ranging from $2.4B in FY2022 to $3.5B in FY2021.
Based on SEC 10-K filings.
$2.6B in FY2025 with a 5-year CAGR of +0.2%. Top quartile in the Health Care sector.
Improved from $2.9B to $2.6B over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +3.1%
- 5-Year CAGR
- +0.2%
- 10-Year CAGR
- -
Sector benchmark
-42.3% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.2%, indicating consistent growth.
- In FY2025, current liabilities increased 5.4% year-over-year.
- Ranks #28 out of 160 companies in the Health Care sector.
- Peak current liabilities was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.6B | +5.4% |
| FY2024 | $2.5B | -14.2% |
| FY2023 | $2.9B | +21.2% |
| FY2022 | $2.4B | -32.0% |
| FY2021 | $3.5B | +35.6% |
| FY2020 | $2.6B | -25.7% |
| FY2019 | $3.4B | +42.1% |
| FY2018 | $2.4B | -21.1% |
| FY2017 | $3.1B | +28.9% |
| FY2016 | $2.4B | +47.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026